World's first kids' malaria vaccine price to be less than USD 5 by 2028
Hyderabad, June 25 (UNI) Bharat Biotech International Limited (BBIL) and GSK plc, a Global Pharma Company, today announced their commitment to Gavi, the Vaccine Alliance (Gavi), in the continued roll out of the world's first malaria vaccine.
Bharat Biotech will be reducing the price of world first malaria vaccine 'RTS.S, developed by GSK, PATH and partners, by more than half, to less than $5 progressively by 2028.
This price reduction is driven by process improvements, expanded production capacity, cost- effective manufacturing, and minimal profit margins, Hyderabad based vaccine maker BBIL said in a release here.
The announcement forms part of pledges to Gavi for its next replenishment phase (Gavi 6.0, 2026-2030) by both companies.
RTS,S was the first malaria vaccine recommended by the World Health Organisation (WHO) in 2021.
Since then, GSK has made significant investments to enhance production capacity and efficiency, and to undertake the planned technology transfer to Bharat Biotech.
In parallel, Bharat Biotech has invested over $200 million in new, higher- output manufacturing facilities, product development and technology transfers.
These enhancements have enabled a phased reduction in the price of the malaria vaccine, starting immediately and fully realised by 2028, when the transfer of production between the two companies is complete.
Through Gavi support, RTS,S expected to be rolled out in 12 endemic countries in Africa through routine immunisation programmes by end of 2025
This has only been possible through the critical work that GSK has undertaken with Bharat Biotech, PATH, together with the WHO, implementing countries, MedAccess and Gavi, to help deliver access to life-saving malaria prevention for children in endemic countries in Africa.
BBIL Executive Chairman Dr. Krishna Ella, said: "Through this historic announcement, we aim to change the course of malaria burden for millions of children and families. By joining forces with GSK, and working closely with Gavi, and the WHO, we are taking a real step toward closing the gap between vaccine supply and the urgent needs of children at risk of malaria'.
In a recent evaluation of impact by the WHO of the Malaria Vaccine Implementation Programme (MVIP) in Ghana, Kenya and Malawi, where over 2 million children received the RTS,S vaccine between 2019 and 2023, the WHO reported a 13 percent reduction in all-cause mortality and a 22 percent reduction in hospitalisations of severe malaria among children age- eligible for vaccination during this period1.
When administered seasonally in regions with high malaria transmission, alongside seasonal malaria chemoprevention, the two malaria vaccines recommended by the WHO, have been shown to prevent around 75 percent of malaria episodes. UNI KNR SSP
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Hindu
35 minutes ago
- The Hindu
A call to rethink masculinity in India: destigmatising men's mental health
June, designated as Men's Mental Health Month, offers a vital opportunity to confront a silent epidemic. In India, where cultural norms often equate masculinity with stoicism, men's mental health remains shrouded in stigma, under-discussed and under-addressed. The statistics are sobering: according to the National Mental Health Survey (2015-16), nearly 15% of Indian adults face mental health challenges, with men disproportionately affected by issues like substance abuse and suicide. Globally, men are three times more likely to die by suicide than women, as per World Health Organization (WHO) data. Yet, societal expectations—rooted in phrases like 'mard ko dard nahi hota' (men don't feel pain)—continue to stifle conversations about men's emotional struggles. The weight of expectations From boyhood, men are conditioned to embody strength, suppress vulnerability, and prioritise provision over self-care. In India, these expectations are amplified by a patriarchal framework that places men as breadwinners and protectors, often at the cost of their emotional well-being. Take Arjun*, a 32-year-old IT professional from Bengaluru, whose story mirrors countless others. After losing his job during a tech layoff in 2023, Arjun grappled with anxiety and sleeplessness. 'I couldn't tell my family,' he shared in a session. 'They depended on me. Admitting I was struggling felt like failing as a man.' Arjun's silence is emblematic of a broader issue: men are taught that emotional expression is weakness, leaving them to internalise pain. Economic pressures exacerbate this. India's rapid urbanisation and competitive job markets pile stress on men, particularly in metro cities where financial stability is equated with self-worth. Social media posts by young men anonymously venting about burnout abound, with hashtags like #MenToo and #MentalHealthMatters. Yet, these digital cries often don't translate into real-world support. Cultural narratives—bolstered by Bollywood's hyper-masculine heroes—reinforce the idea that men must 'tough it out,' whether facing workplace stress, relationship breakdowns, or personal loss. The stigma barrier Stigma is the biggest roadblock to men seeking mental health support. In rural areas, where mental health literacy is low, men are often dismissed as 'weak' or labeled with derogatory terms if they express emotional distress. Urban India fares little better; therapy is still seen as a luxury or a sign of failure. The lack of accessible mental health infrastructure doesn't help. India has just 0.75 psychiatrists per 100,000 people, as per WHO, and mental health services are concentrated in urban centres. For men in tier-2 cities or rural areas, seeking help often means navigating long distances or unaffordable private care. Moreover, mental health campaigns in India rarely target men specifically, focusing instead on women or children. This gap leaves men's issues—like workplace stress, loneliness, or trauma from societal expectations—largely unaddressed. The suicide crisis The most alarming consequence of this neglect is the rising male suicide rate. In 2022, the National Crime Records Bureau reported 1.7 lakh suicides in India, with men accounting for nearly 72%. Young men aged 18-30, grappling with unemployment, academic pressure, or relationship issues, are particularly vulnerable. Men's reluctance to seek help, compounds this crisis. Unlike women, who are more likely to confide in friends or family, men often lack safe spaces for emotional expression. Traditional male friendships in India revolve around banter or shared activities, rarely delving into personal struggles. This isolation drives men toward maladaptive coping mechanisms—alcohol, substance abuse, or aggression. The WHO notes that men in India are twice as likely as women to develop alcohol dependence, often as a response to unaddressed stress. Pathways to change Breaking this cycle demands a multi-pronged approach, starting with dismantling stereotypes. Media plays a crucial role here. Recent movies have normalised therapy, but we need more narratives showcasing men embracing vulnerability. Male voices on social media platforms are already challenging norms by sharing stories of therapy or burnout. Campaigns like 'Movember', which focus on men's health, could gain traction in India with localised efforts, encouraging men to share their vulnerabilities, and address mental health challenges. Education is another cornerstone. Schools must integrate emotional literacy into curricula, teaching boys that vulnerability is strength, not weakness. Community-level initiatives, like men's support groups in villages or workplaces, can create safe spaces for dialogue. Efforts are on in the private sector to offer gender-sensitive mental health programmes for men. Scaling such efforts requires government backing—perhaps through dedicated men's mental health policies or subsidised counselling services. Workplaces, too, must step up. Corporate India's high-pressure environments often glorify overwork, particularly for men. Companies have introduced employee wellness programmes, but these need to explicitly address men's mental health, offering confidential counselling or stress management workshops. Normalising mental health days—akin to sick leave—could reduce burnout. Finally, families play a pivotal role. Encouraging open communication, where men feel safe discussing fears or failures, can bridge the emotional gap. Women, as partners or mothers, can challenge traditional expectations by validating men's emotions rather than dismissing them. A call to action Men's Mental Health Month is more than a calendar event; it is a call to rethink masculinity in India. By fostering a culture where men can express pain without shame, we not only save lives but also build stronger communities. This requires collective effort—from policymakers funding mental health services to individuals challenging stereotypes in daily conversations. Let us strive to create a world where that is true for every man. The path forward isn't easy, but it is urgent. Let us break the silence, one story at a time. *Name changed to protect privacy (Dr. Alok Kulkarni is a senior consultant and interventional psychiatrist at the Manas Institute of Mental Health and Neurosciences, Hubli, Karnataka. alokvkulkarni@
New Indian Express
an hour ago
- New Indian Express
Bharat Biotech to slash malaria vaccine prices by 2028
HYDERABAD: Bharat Biotech International Limited (BBIL) and GSK plc on Wednesday announced a price reduction on the world's first malaria vaccine, RTS.S. The vaccine developed by GSK, PATH and partners will have a price reduction of $5 progressively by 2028. The price reduction is driven by process improvements, expanded production capacity, cost- effective manufacturing. The announcement was made by Bharat Biotech and GSK as a part of Gavi, the Vaccine Alliance, for its next replenishment phase (Gavi 6.0, 2026-2030) by both companies. Dr. Krishna Ella, Executive Chairman of Bharat Biotech International Limited said: 'This pledge to Gavi 6.0 is more than a pricing announcement. It is a commitment to global equity and innovation. Through this historic announcement, we aim to change the course of malaria burden for millions of children and families. For us, this is more than a cooperation, By joining forces with GSK, and working closely with Gavi, and the WHO, we are taking a real step toward closing the gap between vaccine supply and the urgent needs of children at risk of malaria.
Time of India
4 hours ago
- Time of India
GSK, Bharat Biotech to slash malaria vaccine prices to under $5 per dose by 2028
Representative Image HYDERABAD: Vaccine maker Bharat Biotech International Ltd and British biopharma giant GSK plc will be slashing the prices of the world's first malaria vaccine - RTS,S or Mosquirix - by over half to less than $5 per dose by 2028 as part of their pledges to Gavi's replenishment process for 2026-2030. The proposed price reduction will be driven by process improvements, expanded production capacity, cost-effective manufacturing, and minimal profit margins, they said in a joint statement on Wednesday.
